Archive for the 'SciLit' Category

Elucidating Molecular Motion through Structural and Dynamic Filters of Energy-Minimized Conformer Ensembles

September 30, 2016

Elucidating Molecular Motion (compatible w. #NMR relaxation times) through…Filters of Energy-Minimized…Ensembles
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983377

PLOS ONE: Sizing the Problem of Improving Discovery and Access to NIH-Funded Data: A Preliminary Study

September 29, 2016

http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0132735

High-throughput discovery of novel developmental phenotypes : Nature : Nature Research

September 22, 2016

HTP discovery of novel developmental #phenotypes
http://www.nature.com/nature/journal/v537/n7621/full/nature19356.html New list of essential genes for the mouse, upping number to ~2900

Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer | Science

September 19, 2016

high mutational burden predicts responsive patients

http://science.sciencemag.org/content/348/6230/124.long

Inferring regulatory element landscapes and transcription factor networks from cancer methylomes | Genome Biology | Full Text

September 19, 2016

ELMER

https://genomebiology.biomedcentral.com/articles/10.1186/s13059-015-0668-3

The Path to Cancer — Three Strikes and You’re Out — NEJM

September 18, 2016

http://www.nejm.org/doi/full/10.1056/NEJMp1508811

Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions. – PubMed – NCBI

September 18, 2016

http://www.ncbi.nlm.nih.gov/pubmed/25554788

PETModule: a motif module based approach for enhancer target gene prediction : Scientific Reports

September 17, 2016

PETModule…enhancer-target-gene prediction
http://www.nature.com/articles/srep30043 Compares activity
correlations against a Hi-C/ChIA-PET gold std.

Cancer undefeated. – PubMed – NCBI

September 11, 2016

http://www.ncbi.nlm.nih.gov/pubmed/9164814
Bailar JC 3rd1, Gornik HL.NEJM

QT:{{"
Despite decades of basic and clinical research and trials of promising new therapies, cancer remains a major cause of morbidity and mortality. We assessed overall progress against cancer in the United States from 1970 through 1994 by analyzing changes in age-adjusted mortality rates."}}

Treatment of Acute Lymphoblastic Leukemia — 30 Years’ Experience at St. Jude Children’s Research Hospital — NEJM

September 11, 2016

http://www.nejm.org/doi/full/10.1056/NEJM199310283291801#t=article

QT:{{”
When treated with effective multiagent chemotherapy, about two thirds of children with newly diagnosed acute lymphoblastic leukemia survive for long periods of time1-4. Much of this success can be credited to more intensive early treatment, especially of patients at higher risk of relapse.
“}}

Result of Pinkel ’79 study